Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBC

NCT03289819 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Malignant Neoplasm of Breast

Interventions

DRUG: Pembrolizumab
DRUG: nab-paclitaxel
DRUG: Epirubicin
DRUG: Cyclophosphamide

Sponsor

Institut fuer Frauengesundheit

Collaborators

[object Object]
[object Object]